Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BGM GroupBGM +1.42%37 Days Inventory is 133.37 as of Sep. 2025, which is 38% above its 10-year median of 96.96. GuruFocus rates BGM with a GF Score™ of 37/100 and a GF Value™ of $0.25 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 922 Drug Manufacturers companies, BGM Group ranks better than 64.21% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). BGM Group's Average Total Inventories for the
six
months ended in Sep. 2025 was $14.48 Mil. BGM Group's Cost of Goods Sold for the
six
months ended in Sep. 2025 was $19.81 Mil.
Hence, BGM Group's Days Inventory for the
six
months ended in Sep. 2025 was 133.37.
The historical rank and industry rank for BGM Group's Days Inventory or its related term are showing as below:
BGM'
s Days Inventory Range Over the Past 10 Years
Min: 56.6 Med: 96.96 Max: 244.95
Current: 130.88
During the past 9 years, BGM Group's highest Days Inventory was 244.95. The lowest was 56.60. And the median was 96.96.
BGM's Days Inventory is ranked better than 64.21% of 922
companies
in the Drug Manufacturers industry
Industry Median: 165.005
vs BGM: 130.88
BGM Group's Days Inventory
increased
from Sep. 2024 (90.02) to Sep. 2025 (133.37).
It might indicate that BGM Group's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
BGM Group's Inventory Turnover for the
six
months ended in Sep. 2025 was 1.37.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BGM Group's Inventory-to-Revenue for the
six
months ended in Sep. 2025 was 0.61.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BGM Group's Inventory Turnover for the
six
months ended in Sep. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BGM Group's Inventory to Revenue for the
six
months ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BGM Group Days Inventory Related Terms
BGM Group Days Inventory Historical Data
* Premium members only.
The historical data trend for BGM Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGM vs CPIX, ADCT, ZYBT: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, BGM Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BGM Group Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BGM Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where BGM Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGM Group (BGM) has a Days Inventory of 133.37 as of Sep. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BGM Group and its competitors. This is 38% above median its historical median of 96.96. Over the past decade, BGM Group's Days Inventory has ranged from 56.60 to 244.95. According to the industry distribution chart, BGM Group ranks #330 out of 922 companies in the Drug Manufacturers industry, placing it in the top 35.8%.
Is BGM Group's Days Inventory too high?
BGM Group's current Days Inventory of 133.37 is 38% above median its 10-year median of 96.96. Over the past 10 years, this metric has ranged from a low of 56.60 to a high of 244.95. The Drug Manufacturers industry median Days Inventory is 165.01. BGM Group's value of 133.37 is 19.2% below this industry median. Based on the distribution chart, BGM Group ranks #330 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, BGM Group has a GF Score™ of 37/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BGM Group's Days Inventory compare to CPIX and ADCT?
According to the Drug Manufacturers industry distribution chart, BGM Group ranks #330 out of 922 companies for Days Inventory. This puts BGM Group in the upper half of its industry. The industry median Days Inventory is 165.01. BGM Group's value of 133.37 is 19.2% below this benchmark. Historically, BGM Group's own Days Inventory has ranged from 56.60 to 244.95 over the past decade. While the company's 10-year median is 96.96 vs. the industry median of 165.01, BGM Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.01, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BGM Group's current Days Inventory of 133.37 is 19.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BGM Group and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BGM Group's current Days Inventory is 133.37, which is 38% above median its own 10-year median of 96.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BGM Group stock overvalued right now?
Based on GuruFocus' analysis, BGM Group (BGM) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.25, compared to a current price of $0.30 — trading 20.2% above its estimated fair value. The current Days Inventory is 133.37, which is 38% above median its 10-year median of 96.96 and 19.2% below the Drug Manufacturers industry median of 165.01. BGM Group's overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For BGM Group (BGM), the current Days Inventory is 133.37 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BGM Group (BGM) Overvalued in 2026?
Based on GuruFocus' analysis, BGM Group stock appears to be overvalued.
The current stock price of $0.30 is trading 20.2% above its estimated GF Value™ of $0.25.
GuruFocus considers BGM Group to be Modestly Overvalued.
Key valuation signals for BGM:
Days Inventory: 133.37 (38% above median its 10-year median of 96.96)
GF Value™: $0.25 vs. price of $0.30 (20.2% above fair value)
Industry Position: 19.2% below the Drug Manufacturers median (#330 of 922)
No single metric tells the full story. See the BGM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
37GF Score
Get the complete analysis for BGM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGM has been successfully added to your 
